Format

Send to

Choose Destination
See comment in PubMed Commons below
ACS Med Chem Lett. 2011 Dec 8;2(12):907-912.

Design, Synthesis and Biological Evaluation of a Series of Novel Axl Kinase Inhibitors.

Author information

  • 1Center for Investigational Therapeutics, Huntsman Cancer Institute, 2000 Circle of Hope, Salt Lake City, UT 84112, United States.

Abstract

The receptor tyrosine kinase AXL has emerged in recent years as an potential oncology target due to its over expression in several types of cancers coupled with its ability to promote tumor growth and metastasis. In order to identify small molecule inhibitors of AXL, we built a homology model of its catalytic domain to virtually screen and identify scaffolds displaying an affinity for AXL. Further computational and structure-based design resulted in the synthesis of a series of 2,4,5-trisubstitued pyrimidines which demonstrated potent inhibition of AXL in vitro (IC(50) 19 nM) and strongly inhibited the growth of several pancreatic cell lines.

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for American Chemical Society Icon for PubMed Central
    Loading ...
    Write to the Help Desk